ong-term outcome of Moyamoya disease in a single high-volume center; treatment strategy based on cerebral hemodynamic measurements
Not Applicable
Recruiting
- Conditions
- Moyamoya disease
- Registration Number
- JPRN-UMIN000035257
- Lead Sponsor
- Department of Neurosurgery, Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
refusal of the participant
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cerebral hemodynamic changes in Moyamoya disease progression?
How does hemodynamic-guided treatment strategy compare to standard surgical revascularization for Moyamoya outcomes?
Which biomarkers correlate with improved cerebral perfusion in hemodynamic-based Moyamoya management?
What adverse events are associated with hemodynamic monitoring during Moyamoya treatment at Tokyo Medical and Dental University?
Are there combination therapies with cerebral hemodynamic assessment for Moyamoya disease in clinical research?